Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81325020)
  • Personalized Medicines—Molecular Signature-based Drug Discovery and Development
  • Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12040311)

This publication has 48 references indexed in Scilit: